Cancer vaccines and RNA therapeutics: exploring the impact of microRNAs

Read full text Summarise with VIRAT
Authors: Miriam Valeria Rojas-Rojas, Ainhoa Muiños-García, Cristian Arriaga-Canon, Luis Alonso Herrera
Cited by: 0
References: 56

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

RNA-based therapies have been studied for decades, gaining global recognition with the success of the Pfizer-BioNTech mRNA vaccine. Despite ongoing challenges in standardization and optimization, RNA therapeutics have become central to precision medicine. This success has driven interest in oncology applications, particularly microRNAs (miRNAs), which regulate gene expression and cancer-related processes. This article reviews RNA-based cancer therapies, highlighting miRNA potential and clinical translation challenges.

Fields of Study & Subjects

MicroRNA in disease regulation RNA Interference and Gene Delivery Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
npj Vaccines
Volume
11
Issue
1
Publication date
25 March 2026
Language
EN